Literature DB >> 12738851

Boon and bane of metal ions in medicine.

Katherine H Thompson1, Chris Orvig.   

Abstract

In biological systems metal ions promote responses that range from deficiency to toxicity. Some, such as iron and zinc, have a known optimal intake range for normal, healthy individuals. Metal ions contained within well-designed molecules already constitute a great boon for the medicinal pharmacopoeia. However, whether essential or not, the threshold for toxicity can be very low. One of the challenges of designing metal-based drugs is to balance the potential toxicity of an active formulation with the substantial positive impact of these increasingly common therapeutic and diagnostic aids.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12738851     DOI: 10.1126/science.1083004

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  27 in total

Review 1.  Novel metals and metal complexes as platforms for cancer therapy.

Authors:  Michael Frezza; Sarmad Hindo; Di Chen; Andrew Davenport; Sara Schmitt; Dajena Tomco; Q Ping Dou
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

2.  A P-type ATPase importer that discriminates between essential and toxic transition metals.

Authors:  Oded Lewinson; Allen T Lee; Douglas C Rees
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-05       Impact factor: 11.205

Review 3.  Application of metal coordination chemistry to explore and manipulate cell biology.

Authors:  Kathryn L Haas; Katherine J Franz
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

4.  Cellular and computational studies of proteasome inhibition and apoptosis induction in human cancer cells by amino acid Schiff base-copper complexes.

Authors:  Jian Zuo; Caifeng Bi; Yuhua Fan; Daniela Buac; Chiara Nardon; Kenyon G Daniel; Q Ping Dou
Journal:  J Inorg Biochem       Date:  2012-10-15       Impact factor: 4.155

5.  Bioactive cyclometalated phthalimides: design, synthesis and kinase inhibition.

Authors:  Sebastian Blanck; Yann Geisselbrecht; Katja Kräling; Stephen Middel; Thomas Mietke; Klaus Harms; Lars-Oliver Essen; Eric Meggers
Journal:  Dalton Trans       Date:  2012-06-26       Impact factor: 4.390

6.  Inhibition of polyprotein processing and RNA replication of human rhinovirus by pyrrolidine dithiocarbamate involves metal ions.

Authors:  B M Krenn; B Holzer; E Gaudernak; A Triendl; F J van Kuppeveld; J Seipelt
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

7.  Characterization of a versatile organometallic pro-drug (CORM) for experimental CO based therapeutics.

Authors:  João D Seixas; Abhik Mukhopadhyay; Teresa Santos-Silva; Leo E Otterbein; David J Gallo; Sandra S Rodrigues; Bruno H Guerreiro; Ana M L Gonçalves; Nuno Penacho; Ana R Marques; Ana C Coelho; Patrícia M Reis; Maria J Romão; Carlos C Romão
Journal:  Dalton Trans       Date:  2013-05-07       Impact factor: 4.390

8.  Axial ligand exchange of N-heterocyclic cobalt(III) Schiff base complexes: molecular structure and NMR solution dynamics.

Authors:  Lisa M Manus; Robert J Holbrook; Tulay A Atesin; Marie C Heffern; Allison S Harney; Amanda L Eckermann; Thomas J Meade
Journal:  Inorg Chem       Date:  2013-01-02       Impact factor: 5.165

9.  Rational design of [Co(acacen)L2]+ inhibitors of protein function.

Authors:  Lauren M Matosziuk; Robert J Holbrook; Lisa M Manus; Marie C Heffern; Mark A Ratner; Thomas J Meade
Journal:  Dalton Trans       Date:  2013-01-22       Impact factor: 4.390

10.  Novel organometallic cationic ruthenium(II) pentamethylcyclopentadienyl benzenesulfonamide complexes targeted to inhibit carbonic anhydrase.

Authors:  Bradley T Loughrey; Michael L Williams; Peter C Healy; Alessio Innocenti; Daniela Vullo; Claudiu T Supuran; Peter G Parsons; Sally-Ann Poulsen
Journal:  J Biol Inorg Chem       Date:  2009-04-24       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.